Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$29.6M Hold
966,992
2.39% 6
2015
Q3
$28.8M Hold
966,992
1.66% 9
2015
Q2
$30.8M Hold
966,992
1.6% 10
2015
Q1
$31.9M Hold
966,992
1.66% 8
2014
Q4
$28.6M Hold
966,992
1.49% 12
2014
Q3
$27.1M Hold
966,992
1.47% 12
2014
Q2
$27.2M Hold
966,992
1.42% 13
2014
Q1
$29.5M Hold
966,992
1.62% 4
2013
Q4
$28.1M Hold
966,992
1.57% 7
2013
Q3
$26.4M Hold
966,992
1.46% 8
2013
Q2
$25.7M Buy
+966,992
New +$26.7M 1.41% 6

Other funds holding PFE

Chubb Corp's PFE Position: Q4 2015 in Review

Chubb Corp held its Pfizer (PFE) position steady in Q4 2015 at 966,992 shares worth $29.6M. The position accounts for 2.39% of the portfolio, ranked #6.

Chubb Corp first reported a position in PFE in Q2 2013 and has held it in 11 quarters since. The position peaked at $31.9M in Q1 2015. 1,970 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

  • Chubb Corp held 966,992 shares of Pfizer worth $29.6M as of Q4 2015.
  • Chubb Corp left its Pfizer share count unchanged in Q4 2015.
  • Pfizer made up 2.39% of Chubb Corp's portfolio in Q4 2015, its #6 holding.
  • Chubb Corp first reported a position in Pfizer in Q2 2013 and has held it in 11 quarters since.
  • Chubb Corp's Pfizer position peaked at $31.9M in Q1 2015.
  • 1,970 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Chubb Corp's 13F filing for Q4 2015, filed 11 Feb 2016.